Lack of p16/CDKN2 alterations in thyroid carcinomas.
Yane K, Konishi N, Kitahori Y, Naito H, Okaichi K, Ohnishi T, Miyahara H, Matsunaga T, Hiasa Y.
Yane K, et al.
Cancer Lett. 1996 Mar 19;101(1):85-92. doi: 10.1016/0304-3835(96)04117-1.
Cancer Lett. 1996.
PMID: 8625287